{"id":"W4210876307","doi":"10.1016/j.neuropharm.2022.108985","title":"In vivo imaging of alpha-synuclein with antibody-based PET","year":2022,"lang":"en","type":"article","venue":"Neuropharmacology","topic":"Parkinson's Disease Mechanisms and Treatments","field":"Medicine","cited_by":61,"is_retracted":false,"has_abstract":true,"ca_institutions":"Ontario Brain Institute; University of Toronto; University Health Network","funders":"Parkinsonfonden; Uppsala Universitet; Vetenskapsrådet; Knut och Alice Wallenbergs Stiftelse; Science for Life Laboratory; Alzheimerfonden; Hjärnfonden; European Commission","keywords":"Radioligand; Antibody; Alpha-synuclein; Genetically modified mouse; Synucleinopathies; Chemistry; Positron emission tomography; In vivo; Preclinical imaging; Pet imaging; Pathology; Molecular biology; Transgene; Medicine; Nuclear medicine; Receptor; Parkinson's disease; Biology; Immunology; Biochemistry","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00007447069,0.0001243331,0.0002609088,0.0002135195,0.00006021005,0.000002373077,0.00008670132,0.000008902194,0.003423485],"category_scores_gemma":[0.00000857589,0.0001123318,0.00005357337,0.0002636584,0.00005189459,0.00003358648,0.00006188456,0.0001792556,0.000009479237],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00006421211,"about_ca_system_score_gemma":0.0001529591,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00004263305,"about_ca_topic_score_gemma":0.000001575869,"domain_scores_codex":[0.9989756,0.0001406981,0.0001667489,0.0002788577,0.0002021766,0.0002359595],"domain_scores_gemma":[0.9995909,0.00005416908,0.00008262204,0.0001478978,0.00002906966,0.00009537703],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.002691165,0.001801626,0.08473404,0.0000701791,0.00007848926,0.03417823,0.00005008297,0.0004021644,0.8738293,0.00009939323,0.001650082,0.0004152358],"study_design_scores_gemma":[0.06472308,0.00693686,0.2099212,0.00006594521,0.001364794,0.00331008,0.0002061086,0.02235221,0.4723149,0.0001226857,0.217967,0.0007151871],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9972213,0.0001031169,0.0000198482,0.001186462,0.0002474707,0.0003132089,0.00005364502,0.00003185012,0.0008230966],"genre_scores_gemma":[0.9950681,0.00001169727,0.0002308083,0.00436371,0.00002659563,0.00007504317,0.00001237698,0.00002990643,0.0001817971],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.4015144,"threshold_uncertainty_score":0.9974875,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01084205511959363,"score_gpt":0.2976274210765356,"score_spread":0.2867853659569419,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}